Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.33
-0.24 (-1.06%)
At close: Jul 19, 2024, 4:00 PM
23.30
+0.97 (4.34%)
Pre-market: Jul 22, 2024, 6:53 AM EDT

Bicycle Therapeutics Statistics

Total Valuation

BCYC has a market cap or net worth of $951.99 million. The enterprise value is $533.84 million.

Market Cap 951.99M
Enterprise Value 533.84M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date Aug 1, 2024
Ex-Dividend Date n/a

Share Statistics

BCYC has 42.63 million shares outstanding.

Shares Outstanding 42.63M
Owned by Insiders (%) 1.38%
Owned by Institutions (%) 87.96%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.88
Forward PS 33.99
PB Ratio 2.67
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 12.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.42, with a Debt / Equity ratio of 0.11.

Current Ratio 10.42
Quick Ratio 10.02
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -49.81

Financial Efficiency

Return on equity (ROE) is -49.30% and return on invested capital (ROIC) is -45.55%.

Return on Equity (ROE) -49.30%
Return on Assets (ROA) -30.10%
Return on Capital (ROIC) -45.55%
Revenue Per Employee $146,514
Profits Per Employee -$592,123
Employee Count 284
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

In the past 12 months, BCYC has paid $1.73 million in taxes.

Income Tax 1.73M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -9.96% in the last 52 weeks. The beta is 0.93, so BCYC's price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change -9.96%
50-Day Moving Average 22.00
200-Day Moving Average 20.21
Relative Strength Index (RSI) 54.61
Average Volume (20 Days) 195,743

Short Selling Information

Short Interest 2.81M
Short Previous Month 2.78M
Short % of Shares Out 4.30%
Short % of Float n/a
Short Ratio (days to cover) 9.56

Income Statement

In the last 12 months, BCYC had revenue of $41.61 million and -$168.16 million in losses. Loss per share was -$4.42.

Revenue 41.61M
Gross Profit 41.61M
Operating Income -179.86M
Pretax Income -166.44M
Net Income -168.16M
EBITDA -156.52M
EBIT -163.16M
Loss Per Share -$4.42
Full Income Statement

Balance Sheet

The company has $457.00 million in cash and $38.85 million in debt, giving a net cash position of $418.15 million or $9.81 per share.

Cash & Cash Equivalents 457.00M
Total Debt 38.85M
Net Cash 418.15M
Net Cash Per Share $9.81
Equity (Book Value) 356.05M
Book Value Per Share 8.35
Working Capital 466.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.09 million and capital expenditures -$842,000, giving a free cash flow of -$85.93 million.

Operating Cash Flow -85.09M
Capital Expenditures -842,000
Free Cash Flow -85.93M
FCF Per Share -$2.02
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -432.25% and -404.14%.

Gross Margin 100.00%
Operating Margin -432.25%
Pretax Margin -400.00%
Profit Margin -404.14%
EBITDA Margin -376.15%
EBIT Margin -392.12%
FCF Margin -206.51%

Dividends & Yields

BCYC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -41.86%
Shareholder Yield -41.86%
Earnings Yield -17.66%
FCF Yield -9.03%

Analyst Forecast

The average price target for BCYC is $47.25, which is 111.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target $47.25
Price Target Difference 111.60%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 65.25%
EPS Growth Forecast (5Y) -25.67%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BCYC has an Altman Z-Score of 1.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.73
Piotroski F-Score 4